ASTROTECH Corp Fair Value of Assets Acquired
ASTROTECH Corp (ASTC) reported Fair Value of Assets Acquired of $0 for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueOfAssetsAcquired · last filed 2025-09-26
- ASTROTECH Corp fair value of assets acquired for the quarter ending 2024-06-30 was $245.00K.
- ASTROTECH Corp fair value of assets acquired for the quarter ending 2023-06-30 was -$104.00K.
- ASTROTECH Corp fair value of assets acquired for the quarter ending 2023-03-31 was $223.00K.
- ASTROTECH Corp fair value of assets acquired for the quarter ending 2022-06-30 was $0.00.
- ASTROTECH Corp fair value of assets acquired for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- ASTROTECH Corp fair value of assets acquired for fiscal 2024 was $245.00K, a 105.88% increase from fiscal 2023.
- ASTROTECH Corp fair value of assets acquired for fiscal 2023 was $119.00K, a 69.80% decline from fiscal 2022.
- ASTROTECH Corp fair value of assets acquired for fiscal 2022 was $394.00K.
| Period end | Fair Value of Assets Acquired 3 month | Fair Value of Assets Acquired 6 month | Fair Value of Assets Acquired 9 month | Fair Value of Assets Acquired 9 month as first filed | Fair Value of Assets Acquired 12 month |
|---|---|---|---|---|---|
| 2025-06-30 | $0.00 10-K · filed 2025-09-26 | ||||
| 2024-06-30 | $245.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-26 | $245.00K 10-K · filed 2025-09-26 | |||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 | ||||
| 2023-06-30 | -$104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-20 | $119.00K derived: sum of 2 quarters · filed 2024-09-20 | $119.00K 10-K · filed 2024-09-20 | ||
| 2023-03-31 | $223.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-14 | $223.00K 10-Q · filed 2024-05-14 | $0.00 10-Q · filed 2023-05-12 | ||
| 2022-12-31 | $0.00 10-Q · filed 2023-02-13 | ||||
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | $0.00 derived: sum of 2 quarters · filed 2023-09-28 | $394.00K 10-K · filed 2023-09-28 | ||
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-12 | $394.00K 10-Q · filed 2023-05-12 | |||
| 2021-12-31 | $394.00K 10-Q · filed 2023-02-13 | ||||
| 2021-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-15 | $0.00 derived: sum of 2 quarters · filed 2022-09-15 | $0.00 10-K · filed 2022-09-15 | ||
| 2021-03-21 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-13 | $0.00 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | $0.00 10-Q · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |